Medical cannabis is defining healthcare in the 21st century.
Wall Street thinks CBD could be a $16 billion industry by 2025. Here's what the cannabis compound does to your brain and body.
Unpacking The CBD Craze What Does Science Actually Say
The Future of Healthcare: “A second generation of FDA approved medical cannabis” with Dr. Jonathan Rothbard
Stanford Researchers Seek a Solution to Crohn’s with New Cannabis-Focused Biotech Company
The New Small Biotechs Heating Up the Medical Cannabis Space
The Coming Wave of Cannabis-based Medicines
Which Biopharma Stocks Are Looking To Score Big In Cannabis Medicine?
It looks like 2019 may be a blazing year for cannabis. We asked a bunch of successful entrepreneurs what to expect.
Crystal-Gazing For The New Year: 2019 Predictions For The Legal Weed Business
Experts Weight In On Medical Cannabis Products Now Available In The UK
Stanford Researchers Open Medical Cannabis Company with Oral Therapy for MS Pain, Spasticity as Initial Goal
‘A New Way To Treat The Brain’: Stanford University Scientists Launch Cannabis Pharma Company
Academia Joins CBD Research Boom, Offering New Market Opportunities
Katexco Pharmaceuticals To Develop Cannabis Derivative CBD to Suppress Inflammatory Conditions
Stanford Researchers Launch CBD Based Pharmaceutical Company
Stanford University Researchers Form Biotech to Develope Cannabis-Based Therapeutics